Invitae Corp. (NVTA)

21.68
0.22 1.00
NYSE : Health Services
Prev Close 21.90
Open 21.73
Day Low/High 21.41 / 22.26
52 Wk Low/High 9.04 / 28.75
Volume 2.03M
Avg Volume 2.31M
Exchange NYSE
Shares Outstanding 95.17M
Market Cap 2.08B
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
Invitae To Present At The Canaccord Genuity 36th Annual Growth Conference

Invitae To Present At The Canaccord Genuity 36th Annual Growth Conference

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that members of the company's management team will present at the Canaccord Genuity 36th Annual Growth Conference on Thursday, August...

Invitae To Announce Second Quarter 2016 Financial Results And Host Conference Call On August 8, 2016

Invitae To Announce Second Quarter 2016 Financial Results And Host Conference Call On August 8, 2016

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it will report its second quarter 2016 financial results on Monday, August 8, 2016 and will host a conference call that day at...

Invitae Introduces New Breast Cancer STAT Panel For Patients With Breast Cancer Who Need Rapid Test Results To Guide Surgical Decisions

Invitae Introduces New Breast Cancer STAT Panel For Patients With Breast Cancer Who Need Rapid Test Results To Guide Surgical Decisions

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that the company now offers a new Breast Cancer STAT Panel of high-quality genetic testing designed for breast cancer patients whose...

Invitae Contributes More Than 10,000 Additional Genetic Variants To The ClinVar Project

Invitae Contributes More Than 10,000 Additional Genetic Variants To The ClinVar Project

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that the company has submitted information on more than 10,000 clinically observed genetic variants to the ClinVar project, an...

Invitae is Now Oversold (NVTA)

Invitae is Now Oversold (NVTA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Veracyte Dips After CMS Proposes Reimbursement Rate Reduction

Veracyte Dips After CMS Proposes Reimbursement Rate Reduction

Shares of Veracyte are sliding after the Centers for Medicare and Medicaid Services, or CMS, proposed a reimbursement rate reduction on the company's Afirma GEC diagnostic test.

Invitae Announces The Launch Of CancerCHECK To Guide And Support Community Oncologists Through The Hereditary Cancer Genetic Testing Process

Invitae Announces The Launch Of CancerCHECK To Guide And Support Community Oncologists Through The Hereditary Cancer Genetic Testing Process

To help community oncologists more easily follow clinical guidelines on the use of genetic testing, Invitae Corporation (NYSE: NVTA), a genetic information company, today announced the availability of CancerCHECK...

Invitae Now Offers Comprehensive, High-Quality, Affordable Genetic Testing In New York For Hereditary Cancer, Cardiology, And Epilepsy

Invitae Now Offers Comprehensive, High-Quality, Affordable Genetic Testing In New York For Hereditary Cancer, Cardiology, And Epilepsy

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that the company has completed the comprehensive Clinical Laboratory Evaluation Program and received its clinical laboratory permit...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALN, BRC, CNBKA, EROS, FLO, GG, NEWM Downgrades: ACLS, CTL, EVC, GMT, HY, KORS, NVTA, PHM, PX, QADA, QADB Initiations: EPRS Read on to get TheStreet Quant Ratings' detailed report:

Invitae To Present At The UBS Global Healthcare Conference

Invitae To Present At The UBS Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that members of the company's management team will present at the UBS Global Healthcare Conference on Monday, May 23, 2016 at...

Invitae Announces First Quarter 2016 Financial Results

Invitae Announces First Quarter 2016 Financial Results

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced financial and operating results for the first quarter ended March 31, 2016.

Invitae To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference

Invitae To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that members of the company's management team will present at the Bank of America Merrill Lynch 2016 Health Care Conference on...

Invitae To Announce First Quarter 2016 Financial Results And Host Conference Call On May 9, 2016

Invitae To Announce First Quarter 2016 Financial Results And Host Conference Call On May 9, 2016

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will report its first quarter 2016 financial results on Monday, May 9, 2016 and will host a conference call that day at 4:45...

Invitae Announces Medicare Reimbursement For Hereditary Breast Cancer-Related Disorders Under A New CPT Code For Multi-Gene Panels

Invitae Announces Medicare Reimbursement For Hereditary Breast Cancer-Related Disorders Under A New CPT Code For Multi-Gene Panels

Invitae Corporation (NYSE:NVTA), a genetic information company, announced that the Centers for Medicare and Medicaid Services (CMS) have begun providing payments for Invitae's multi-gene tests for hereditary breast...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHMT, FMC, GHC, IBM, MGA, MUX, NVTA, PDVW, RAS Downgrades: SCMP, UEPS Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Invitae Presented Data At The NCCN Annual Conference On The Utility Of Multi-Gene Panels

Invitae Presented Data At The NCCN Annual Conference On The Utility Of Multi-Gene Panels

Invitae Corporation (NYSE:NVTA), a genetic information company, presented data on its guidelines-based genetic testing panels at the NCCN Annual Conference: Advancing the Standard of Cancer Care in Hollywood,...

Invitae Expands Its Comprehensive, High-quality, Affordable Genetic Tests (Graphic: Business Wire)

Invitae Expands Its Comprehensive, High-quality, Affordable Genetic Tests (Graphic: Business Wire)

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and expanded panels for neurology, pediatrics, and...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AF, ALLE, LH, LLL, LMCA, MXIM, NVEE, TSRI, VEEV, VLP, WIFI, WPT Downgrades: HAWK, MS Initiations: AJX, BLCM, INOV, NVTA Read on to get TheStreet Quant Ratings' detailed report:

New Data On Rare Diseases Demonstrate Impact Of Delayed Diagnosis And Obstacles For Patients And Clinicians, Including Lack Of Information, Time To Diagnosis, And Accessibility Due To Cost. (Photo: Business Wire)

New Data On Rare Diseases Demonstrate Impact Of Delayed Diagnosis And Obstacles For Patients And Clinicians, Including Lack Of Information, Time To Diagnosis, And Accessibility Due To Cost. (Photo: Business Wire)

Invitae Corporation (NYSE:NVTA), a genetic information company, today presented data showing that both patients and clinicians in the rare disease community face significant obstacles navigating the diagnosis of...

Invitae Presents New Data Demonstrating High Concordance Of Variant Classifications For BRCA1/2 Across Major Clinical Testing Laboratories

Invitae Presents New Data Demonstrating High Concordance Of Variant Classifications For BRCA1/2 Across Major Clinical Testing Laboratories

Invitae Corporation (NYSE:NVTA), a genetic information company, today presented an important study at the 2016 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting,...

Commit To Purchase Invitae Corp At $7.50, Earn 25.8% Annualized Using Options

Commit To Purchase Invitae Corp At $7.50, Earn 25.8% Annualized Using Options

Investors eyeing a purchase of Invitae Corp shares, but tentative about paying the going market price of $9.03/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $7.50 strike, which has a bid at the time of this writing of $1.05.

Invitae To Present A Dozen Posters And Presentations At The 2016 American College Of Medical Genetics Annual Clinical Genetics Meeting

Invitae To Present A Dozen Posters And Presentations At The 2016 American College Of Medical Genetics Annual Clinical Genetics Meeting

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced it will be presenting a dozen posters and presentations at the 2016 American College of Medical Genetics (ACMG) Annual Clinical...

Invitae To Present At The Cowen And Company 36th Annual Health Care Conference

Invitae To Present At The Cowen And Company 36th Annual Health Care Conference

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that members of the company's management team will present at the Cowen and Company 36th Annual Health Care Conference on Monday,...

Invitae Announces Full Year 2015 Financial Results And 2016 Business Objectives

Invitae Announces Full Year 2015 Financial Results And 2016 Business Objectives

Invitae Corporation (NYSE: NVTA) today reported financial and operating results for the fourth quarter and full year ended December 31, 2015.

Invitae To Announce Fourth Quarter And Year-End 2015 Financial Results And Host Conference Call On February 9, 2016

Invitae To Announce Fourth Quarter And Year-End 2015 Financial Results And Host Conference Call On February 9, 2016

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it will report its fourth quarter and year-end 2015 financial results on Tuesday, February 9, 2016, and Invitae's management team...

Invitae Announces It Met Volume Guidance By Delivering Nearly 19,000 Billable Tests In 2015 And Sets Volume Guidance At 50,000-70,000 Billable Tests For 2016

Invitae Announces It Met Volume Guidance By Delivering Nearly 19,000 Billable Tests In 2015 And Sets Volume Guidance At 50,000-70,000 Billable Tests For 2016

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it met its volume guidance of 17,000-19,000 billable tests delivered in 2015, delivering nearly 19,000 billable tests for the...

5 Stocks Under $10 Setting Up to Trade Higher

5 Stocks Under $10 Setting Up to Trade Higher

Here's how to trade five low-priced stocks poised to move higher.

Invitae Announces Expansion Of Its Epilepsy Test Menu

Invitae Announces Expansion Of Its Epilepsy Test Menu

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it has expanded its epilepsy testing menu, now offering an extensive panel with more than 100 carefully curated genes that...

Invitae Announces Expansion Of Hereditary Cancer Testing Menu

Invitae Announces Expansion Of Hereditary Cancer Testing Menu

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its hereditary cancer genetic testing menu, now offering an even more comprehensive testing menu that covers all...

TheStreet Quant Rating: D (Sell)